Jibeier Pharmaceutical
68856624.031.09% ( +0.26 )
Jibeier Pharmaceutical (688566)
Jiangsu Jibeier Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the drug research and development and production in China. The company’s products...
- Open
- 23.80
- High
- 24.28
- Low
- 23.80
- Prev. Close
- 23.77
- Volume
- 6.47K
- Turnover
- 15.57M
- Avg Price
- 24.07
- Bid/Ask Ratio
- --
- Amplitude
- 2.02%
- 52wk High
- 44.16
- Volume Ratio
- 0.76
- Turnover Ratio
- 0.32%
Jibeier Pharmaceutical Analyst Rating
View MoreForecast & Rating
Feb 19, 2025Price forecast
¥32.5435.64%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- London Stock Exchange · 2 days ago, 05:06 AM
REG - GSK PLC - Hansoh positive 2nd Phase III results for Riz-Rez
- benzinga_article · Jul 24 at 05:25 AM
Two Years to Build or Pay 200% — Which US Pharma Stocks Win?
- Zhitong · Oct 30, 2025 at 03:45 AM
Jibeier Pharmaceutical: Results of Phase III Clinical Trial for New Antidepressant JJH201501 Released
- Zhitong · Oct 28, 2025 at 10:19 PM
Caitong Securities: The demand for phosphonamide monomers will flourish, and multinational pharmaceutical companies' supply chain enterprises are expected to benefit
- Zhitong · Oct 23, 2025 at 03:13 AM
Jibeier Pharmaceutical: Application for the listing of the chemical raw material drug Gatifloxacin has been approved
- Zhitong · Jul 10, 2025 at 03:38 AM
Jibeier Pharmaceutical: The investigational anti-tumor new drug injectable JJH201601 liposome has obtained approval for clinical trials
